Immunofluorescence Assay Market Size & Share Analysis - Growth Trends & Forecasts (2025 - 2030)

The Report Covers Immunofluorescence Assay Market Analysis and it is Segmented by Product (Reagents and Kits, Instruments, Consumables & Accessories), Type (Indirect Immunofluorescence, and Direct Immunofluorescence), Application (Cancer, Infectious Diseases, Autoimmune Diseases, and Others), and Geography (North America, Europe, Asia-Pacific, Middle-East and Africa, and South America). The Market values are Provided in (USD million) for the above segments.

Immunofluorescence Assay Market Size & Share Analysis - Growth Trends & Forecasts (2025 - 2030)

Immunofluorescence Assay Market Size

Immunofluorescence Assay Market Analysis
Study Period 2019 - 2030
Base Year For Estimation 2024
Forecast Data Period 2025 - 2030
CAGR 5.80 %
Fastest Growing Market Asia Pacific
Largest Market North America
Market Concentration Medium

Major Players

Global Immunofluorescence Assay Market Major Players

*Disclaimer: Major Players sorted in no particular order

Compare market size and growth of Global Immunofluorescence Assay Market with other markets in Healthcare Industry

Biotechnology

Pharmaceuticals

Healthcare IT

Medical Devices

Animal Health

Device Drug Combination

Immunofluorescence Assay Market Analysis

The Global Immunofluorescence Assay Market is expected to register a CAGR of 5.8% during the forecast period.

The studied market was impacted by the pandemic. The SARS-CoV-2 outbreak emerged as a potential opportunity for the market's growth. Several research organizations and biopharmaceutical companies are evaluating immunofluorescence assay to develop it as an effective diagnostic tool. The article 'A Novel Immunofluorescence Assay for the rapid serological detection of SARS-CoV-2 infection' published in April 2021, mentions the design of a cell-based fluorescent serology assay to detect SARS-CoV-2 infection. The assay is based on the capture of IgG antibodies in the serum of COVID-19-positive patients using cells exogenously expressing SARS-COV-2 spike and their subsequent fluorescent detection. Such novel immunofluorescent assays implemented to detect COVID-19 infections are expected to impact the growth of the market studied. Also, the article titled 'Rapid Lateral flow immunoassay for the fluorescence detection of SARS-CoV-2 RNA' published in December 2020 mentioned that amplification-free nucleic acid immunoassay, implemented on a lateral flow strip for the fluorescence detection of SARS-CoV-2, achieved sensitivities of 100% and specificities of 99% for both types of throat and sputum samples of COVID-19. The article titled 'Evaluating the serological status of COVID-19 patients using an indirect immunofluorescent assay, France' published in May 2020 mentioned that the immunofluorescence assay is useful for monitoring SARS-CoV-2 exposure at the individual and population levels. The effectiveness of these assays for detecting COVID-19 infection is expected to impact the growth of the market studied. Thus, the market was adversely impacted during the initial phase of the pandemic however, its advantages to diagnose COVID are expected to increase its growth during the upcoming period.

The major factor attributing to the growth of the market is the increase in the incidence of disease. Cancer is a major chronic disease in regions such as the Americas, Asia, and Europe. As further research and development activities are being conducted in the area with huge funding from the government, the market studied is expected to grow significantly over time. For instance, as per the Joint Research Commission's report of European Commission released in July 2020, it was estimated that in 2020 about 2.7 million (excluding non-melanoma cancer) new cancer cases would be diagnosed in the European Union, and breast cancer will be the most prevalent form of cancer with about 355,000 new cases in 2020. These conditions of chronic kidney disorders increase the demand for immunofluorescence assay. The American Cancer Society's estimates for primary liver cancer and intrahepatic bile duct cancer in the United States for 2020 include about 42,810 new cases (30,170 in men and 12,640 in women) diagnosed. According to the study published in Clinical Infectious Diseases, titled 'Re-emergence of Invasive Pneumococcal Disease (IPD) in Germany during the Spring and Summer of 2021' in February 2022, in April 2021, IPD levels in children aged 0 to 4 years old began to rebound to baseline levels. By June 2021, they had surpassed them (a 9 percent increase over the average monthly values for 2015-2019). IPD cases increased beyond baseline values in children 5 to 14, adults 15-34, and people 80 years and older beginning in July 2021, with increases, also beginning in Spring 2021. Such prevalence of infectious diseases is expected to drive the growth of the market studied.

Similarly, initiatives by market players are another factor in market growth. In September 2022, in order to enable subcellular spatial multi-omics measurement with the simultaneous detection of RNA and proteins during a typical MERFISH experiment, Vizgen introduced the MERSCOPE Protein Co-detection Kit. With its oligo conjugated antibodies, the MERSCOPE Protein Stain Reagent Kit enhances the detection of primary antibodies that are directed at proteins and provides high-quality protein staining that is comparable to protein immunofluorescence staining. Thus, the abovementioned factors are expected to increase the market growth.

However, the gaining popularity of the alternative procedures is the major drawback of the market growth

Immunofluorescence Assay Industry Overview

The Immunofluorescence Assay market is moderately competitive and consists of several major players. Some of the companies which are currently dominating the market are Thermo Fisher, Werfen, Bio-Rad Laboratories, Inc., Abcam, PerkinElmer Inc., Merck Millipore, Cell Signaling Technology, Sino Biological, Danaher.

Immunofluorescence Assay Market Leaders

  1. Thermo Fisher

  2. Bio-Rad Laboratories, Inc.

  3. Abcam

  4. PerkinElmer Inc.

  5. Werfen

  6. *Disclaimer: Major Players sorted in no particular order
11.png
Need More Details on Market Players and Competiters?
Download PDF

Immunofluorescence Assay Market News

  • In September 2022, Propath UK and Nucleai collaborated to develop and validate a 30-plex immunofluorescence panel focused on protein targets relevant to immuno-oncology.
  • In January 2022, Thermo Fisher Scientific Inc. acquired PeproTech for a total cash purchase of approximately USD 1.85 billion. The company products included various ELISA immnunoflourence kits.

Immunofluorescence Assay Market Report - Table of Contents

1. INTRODUCTION

  • 1.1 Study Assumptions and Market Defintion
  • 1.2 Scope of the Study

2. RESEARCH METHODOLOGY

3. EXECUTIVE SUMMARY

4. MARKET DYNAMICS

  • 4.1 Market Overview
  • 4.2 Market Drivers
    • 4.2.1 Increasing Incidence of Cancer and Other Infectious Diseases
    • 4.2.2 Growing Investments By Government and Non-government Organizations
  • 4.3 Market Restraints
    • 4.3.1 Upsurge of Alternative Tests Which are More Effective
  • 4.4 Porter's Five Force Analysis
    • 4.4.1 Threat of New Entrants
    • 4.4.2 Bargaining Power of Buyers/Consumers
    • 4.4.3 Bargaining Power of Suppliers
    • 4.4.4 Threat of Substitute Products
    • 4.4.5 Intensity of Competitive Rivalry

5. MARKET SEGMENTATION (Market Size by Value - USD million)

  • 5.1 By Product
    • 5.1.1 Reagents and Kits
    • 5.1.2 Instruments
    • 5.1.3 Consumables & Accessories
  • 5.2 By Type
    • 5.2.1 Indirect Immunofluorescence
    • 5.2.2 Direct Immunofluorescence
  • 5.3 By Application
    • 5.3.1 Cancer
    • 5.3.2 Infectious Diseases
    • 5.3.3 Autoimmune Diseases
    • 5.3.4 Others
  • 5.4 Geography
    • 5.4.1 North America
    • 5.4.1.1 United States
    • 5.4.1.2 Canada
    • 5.4.1.3 Mexico
    • 5.4.2 Europe
    • 5.4.2.1 Germany
    • 5.4.2.2 United Kingdom
    • 5.4.2.3 France
    • 5.4.2.4 Italy
    • 5.4.2.5 Spain
    • 5.4.2.6 Rest of Europe
    • 5.4.3 Asia-Pacific
    • 5.4.3.1 China
    • 5.4.3.2 Japan
    • 5.4.3.3 India
    • 5.4.3.4 Australia
    • 5.4.3.5 South Korea
    • 5.4.3.6 Rest of Asia-Pacific
    • 5.4.4 Middle East and Africa
    • 5.4.4.1 GCC
    • 5.4.4.2 South Africa
    • 5.4.4.3 Rest of Middle East and Africa
    • 5.4.5 South America
    • 5.4.5.1 Brazil
    • 5.4.5.2 Argentina
    • 5.4.5.3 Rest of South America

6. COMPETITIVE LANDSCAPE

  • 6.1 Company Profiles
    • 6.1.1 Abcam
    • 6.1.2 Becton, Dickinson and Company
    • 6.1.3 Bio-Rad Laboratories, Inc.
    • 6.1.4 Cell Signaling Technology
    • 6.1.5 Danaher Corporation
    • 6.1.6 Enzo Life Sciences, Inc.
    • 6.1.7 Werfen
    • 6.1.8 Merck Millipore (Merck KGaA)
    • 6.1.9 PerkinElmer Inc.
    • 6.1.10 Sino Biological
    • 6.1.11 Thermo Fisher Scientific Inc.
  • *List Not Exhaustive

7. MARKET OPPORTUNITIES AND FUTURE TRENDS

**Subject to Availability
**Competitive Landscape covers- Business Overview, Financials, Products and Strategies and Recent Developments
You Can Purchase Parts Of This Report. Check Out Prices For Specific Sections
Get Price Break-up Now

Immunofluorescence Assay Industry Segmentation

As per the scope of the report, immunofluorescence is the specific antigen and antibody reaction where the antibodies are labeled with a fluorescent dye, and the antigen-antibody complex is visualized using a fluorescent microscope. This immunochemical technique allows the detection and localization of a wide variety of antigens in different types of tissues of various cell preparations. The immunofluorescence assay market is segmented by product (reagents and kits, instruments, consumables & accessories), type (indirect immunofluorescence, and direct immunofluorescence), application (cancer, infectious diseases, autoimmune diseases, and others), and geography (North America, Europe, Asia-Pacific, Middle-East and Africa, and South America). The market report also covers the estimated market sizes and trends for 17 different countries across the major regions globally. The report offers the values (USD million) for the above segments.

By Product Reagents and Kits
Instruments
Consumables & Accessories
By Type Indirect Immunofluorescence
Direct Immunofluorescence
By Application Cancer
Infectious Diseases
Autoimmune Diseases
Others
Geography North America United States
Canada
Mexico
Europe Germany
United Kingdom
France
Italy
Spain
Rest of Europe
Asia-Pacific China
Japan
India
Australia
South Korea
Rest of Asia-Pacific
Middle East and Africa GCC
South Africa
Rest of Middle East and Africa
South America Brazil
Argentina
Rest of South America
Need A Different Region or Segment?
Customize Now

Immunofluorescence Assay Market Research FAQs

What is the current Global Immunofluorescence Assay Market size?

The Global Immunofluorescence Assay Market is projected to register a CAGR of 5.8% during the forecast period (2025-2030)

Who are the key players in Global Immunofluorescence Assay Market?

Thermo Fisher, Bio-Rad Laboratories, Inc., Abcam, PerkinElmer Inc. and Werfen are the major companies operating in the Global Immunofluorescence Assay Market.

Which is the fastest growing region in Global Immunofluorescence Assay Market?

Asia Pacific is estimated to grow at the highest CAGR over the forecast period (2025-2030).

Which region has the biggest share in Global Immunofluorescence Assay Market?

In 2025, the North America accounts for the largest market share in Global Immunofluorescence Assay Market.

What years does this Global Immunofluorescence Assay Market cover?

The report covers the Global Immunofluorescence Assay Market historical market size for years: 2019, 2020, 2021, 2022, 2023 and 2024. The report also forecasts the Global Immunofluorescence Assay Market size for years: 2025, 2026, 2027, 2028, 2029 and 2030.

Immunofluorescence Assay Industry Report

Statistics for the 2025 Global Immunofluorescence Assay market share, size and revenue growth rate, created by Mordor Intelligence™ Industry Reports. Global Immunofluorescence Assay analysis includes a market forecast outlook for 2025 to 2030 and historical overview. Get a sample of this industry analysis as a free report PDF download.